• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Prescription Generic Drugs, 6th Edition

$995.00 – $7,990.00

Clear
SKU: KLI1614095 Categories: Pharmaceuticals Market Research, Prescription Drugs Market Reports Pages: 250
  • Description
  • Table of Contents
  • Latest reports

Description

Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected to be rocked by increased competition from companies in Eastern Europe, India and China, as well as brand name companies seeking to protect their franchises by moving into generics.

Kalorama Information’s World Market for Prescription Generic Drugs, 6th Edition is your guide to this formidable and important participant in the complex world of healthcare. Included are market size and forecast revnues for:

    • Allergy and Respiaratory Drugs
    • Analgesics, NAIDS, and Antirheumatic Drugs
    • Anesthesia Drugs
    • Anti-Infectives
    • Cancer Drugs
    • Cardiovascular Drugs
    • Central Nervous System and Psychotherapeutic Drugs
    • Gastrointestinal Drugs
    • Ophthalmic Drugs

 

This report is the result of primary research and secondary research. Interviews with experts in the generic industry form the basis of this report. Research was conducted from available company reports, trade publications and medical and government databases. Interviews with experts are the source of models.

For each drug segment, the report provides:

 

  • Estimated Generic Market Size
  • Forecast to 2012
  • Recent ANDA Approvals
  • World and US Market Share
  • Company Profiles

 

 

Knowledge of the issues that face the generics industry is essential to understanding the market. The report discusses the following trends:

 

  • Legislative Issues
  • Big Pharma Tactics
  • Authorized Generics
  • Generic Biologics
  • Medicaid Generic Drug Reimbursement
  • The Elderly
  • Confusion in Generic Names
  • Broadening Generic Horizons
  • International Generic Drug Issues
  • Indian Drug Makers
  • Industry Consolidation
  • New Generic Giants
  • Patent Issues
  • Generic Companies Increasingly Aggressive
  • Patent Reform
  • Generic Growth
  • Generic Statins
  • Cost
  • Generics Improve Compliance
  • Generic Drug Sampling

 

Marketing executives, business development managers and brand and generic pharmaceutical companies, consultants and investors are among those who will benefit from this report.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Trends Affecting the Market
  • Market Outlook

CHAPTER TWO:INTRODUCTION

  • Industry Development
  • Generic Drug Industry Evolution
  • FDA Regulation
    • Development and Approval Process
  • Industry Structure
  • Product Distribution
  • Patent Expirations

CHAPTER THREE: ALLERGY AND RESPIRATORY DRUGS

  • Product Categories
    • Asthma, Bronchodilators and Corticosteroids
    • Inhaled Corticosteroids
    • Antiasthmatic Agents
    • Bronchodilating Agents
    • Antihistamines, Decongestants, and Cough Preparations
    • Antihistamines
    • Decongestants
    • Cough Preparations
  • Product News
  • Market Size and Forecast
    • The World Market
    • The U.S. vs World Market
  • Competitive Analysis

CHAPTER FOUR: ANALGESICS, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, AND ANTIRHEUMATIC DRUGS

  • Product Categories
    • Analgesics
    • Nonsteroidal Anti-inflammatory Drugs
    • Antirheumatics
  • Product News
  • Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
  • Competitive Analysis

CHAPTER FIVE: ANESTHESIA DRUGS

  • Product Categories
  • General
  • Local
  • Regional
  • Product News
  • Market Size and Forecast
  • The World Market
  • The U.S. vs World Market

CHAPTER SIX: ANTI-INFECTIVES

  • Product Categories
  • Systemic Anti-Infectives
  • Topical Anti-Infectives
  • Product News
  • Market Size and Forecast
  • The World Market
  • The U.S. vs World Market

Competitive AnalysisCHAPTER SEVEN: CANCER DRUGS

  • Products
  • Product News
  • Market Size and Forecast
  • The World Marke
  • The U.S. vs World Market
  • Competitive Analysis

CHAPTER EIGHT: CARDIOVASCULAR DRUGS

  • Product Categories
    • Positive Inotropic Agents
    • Antiadrenergics
    • Beta-Adrenergic Blocking Agents
    • Vasodilators
    • Calcium Channel Blockers
    • Angiotensin-Converting Enzyme Inhibitors
    • Antiarrhythmics
    • Antihyperlipidemic Agents
    • Anticoagulants
    • Diuretics
  • Product News
  • Market Size and Forecast
  • The World Market
  • The U.S. vs. World Market
  • Competitive Analysis

CHAPTER NINE: CENTRAL NERVOUS SYSTEM AND PSYCHOTHERAPEUTIC DRUGS

  • Product Categories
    • Antidepressants, Stimulants, and Antipsychotics
    • Antidepressants
    • Stimulants
    • Antipsychotics
    • Anticonvulsants, Antispasmodics, and Muscle Relaxants
    • Anticonvulsants
    • Antispasmodics
    • Muscle Relaxants
    • Parkinson’s Disease, Myasthenia Gravis, and Multiple Sclerosis
    • Parkinson’s Disease
    • Myasthenia Gravis
    • Multiple Sclerosis
    • Sedatives, Hypnotics, and Antianxiety Drugs
  • Product News
  • Market Size and Forecast
  • The World Market
  • The U.S. vs World Market
  • Competitive Analysis

CHAPTER TEN: GASTROINTESTINAL DRUGS

  • Product Categories
  • Antidiarrheals
  • Antinauseants
  • Antispasmodics
  • Antiulcer
  • Digestants
  • Product News
  • Market Size and Forecast
  • The World Market
  • The U.S. vs the World Market
  • Competitive Analysis

CHAPTER ELEVEN: HORMONAL DRUGS

  • Product Categories
  • Male and Female Hormones
  • Bone Metabolism Regulators
  • Corticosteroids
  • Diabetes Drugs
  • Thyroid Drugs
  • Product News
  • Market Size and Forecast
  • The World Market
  • U.S. vs World Market
  • Competitive Analysis

CHAPTER TWELVE: OPHTHALMIC DRUGS

  • Product Categories
    • Ophthalmic Anti-Infectives
    • Ophthalmic Anti-Inflammatories and Mast Cell Inhibitors
    • Glaucoma Agents
  • Product News
  • Market Size and Forecast
  • The World Market
  • U.S. vs World Market
  • Competitive Analysis

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

  • Overview
  • Total Market Size and Forecast
  • Market and Competitive Analysis

CHAPTER FOURTEEN: ISSUES AND TRENDS

  • Understanding Hatch-Waxman and Its Shortfalls
  • The FDA, Funding and Review Times
  • Big Pharma Tactics—Defensive and Offensive
  • Authorized Generics
  • Generic Biologics
  • Medicaid Generic Drug Reimbursement Issues
  • The Elderly
  • Confusion in Generic Drug Names
  • Broadening Generic Horizons
  • International Generic Drug Issues
  • Indian Drug Makers
  • Industry Consolidation
  • New Generic Giants
  • Patent Issues: Filings and Challenges
  • Generic Companies Increasingly Aggressive
  • Patent Reform
  • Generic Growth: Prescriptions, Approvals, Impact
  • Generic Statins Countdown
  • Prescription Drug Costs
  • Generics Improve Compliance
  • Generic Drug Sampling

CHAPTER FIFTEEN: COMPANY PROFILES

  • Industry Structure and Participants
  • Actavis Group
  • APOTEX, Inc.
  • Aurobindo Pharma, Ltd
  • Barr Laboratories, Inc.
  • Bedford Laboratories
  • Dr Reddy’s Laboratories Limited
  • Dragon Pharmaceuticals, Inc.
  • Hospira Inc.
  • Mylan Laboratories, Inc.
  • Orchid Chemicals and Pharmaceuticals, Ltd.
  • Par Pharmaceuticals, Inc.
  • Perrigo Company
  • PLIVA Pharmaceuticals, Inc.
  • Ranbaxy Laboratories, Ltd.
  • Roxane Laboratories, Inc.
  • Sandoz
  • Taro Pharmaceutical Industries Ltd.
  • TEVA Pharmaceutical Industries, Ltd.
  • Watson Pharmaceuticals, Inc.
  • United Research Laboratories and Mutual Pharmaceutical Company
  • Zydus Pharmaceuticals, Inc.

APPENDIX: COMPANY DIRECTORY

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Figure 1-1: The World Market for Prescription Generic Drugs Revenues by Segment 2002-201

CHAPTER TWO: INTRODUCTION

  • Figure 2-1: Abbreviated New Drug Application Review Flow Chart
  • Table 2-1: Brand Name Companies with Generic Subsidiaries
  • Table 2-2: Number of Best Selling Drugs with Patents Expiring in Years 2006-2012 Grouped by Treatment Category
  • Table 2-3: Best Selling Prescription Drugs with Expected Patent Expiration (Year of Expiration, Brand, Manufacturer, Indication, 2007 Revenues) 2006-2012

CHAPTER THREE:ALLERGY AND RESPIRATORY DRUGS

  • Table 3-1: Prescription Allergy and Respiratory ANDA Approvals, 2006-2007
  • Table 3-2: The World Market for Prescription Generic Allergy and Respiratory Drugs by Type 2002-2012
  • Figure 3-1: The World Market for Prescription Generic Allergy and Respiratory Drugs, Revenues by Type 2002-2012
  • Table 3-3: The World Market for Prescription Generic Allergy and Respiratory Drugs, Market Share by Type 2002-2012
  • Table 3-4: The World Market for Prescription Generic Allergy and Respiratory Drugs, U.S. Revenues and Share 2002-2012
  • Figure 3-2: The World Market for Prescription Generic Allergy and Respiratory Drugs, Displaying U.S. Revenues 2002-2012
  • Table 3.5: The World Market for Prescription Generic Allergy and Respiratory Drugs, Revenues and Market Share by Supplier 2007
  • Figure 3-3: The World Market for Prescription Generic Allergy and Respiratory Drugs, Market Share by Leading Supplier 2005

CHAPTER FOUR: ANALGESICS, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, AND ANTIRHEUMATIC DRUGS

  • Table 4-1: Prescription Generic Analgesic, NSAID, and Antirheumatic ANDA Approvals, 2005
  • Table 4-2: The World Market for Prescription Generic Analgesics, NSAIDs and Antirheumatic Drugs by Type 2002-2012
  • Figure 4-1: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, Revenues by Type 2002-2012
  • Table 4-3: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, Market Share by Type 2002-2012
  • Table 4-4: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs, U.S. Revenues and Share 2002-2012
  • Figure 4-2: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Displaying U.S. Revenues 2002-2012
  • Table 4-5: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Revenues and Market Share by Supplier 2007
  • Figure 4-3: The World Market for Prescription Generic Analgesics, NSAIDs, and Antirheumatic Drugs Market Share by Leading Supplier 2007

CHAPTER FIVE: ANESTHESIA DRUGS

  • Table 5-1: Prescription Generic Anesthesia Drug ANDA Approvals, 2006
  • Table 5-2: The World Market for Prescription Generic Anesthesia Drugs 2002-2012
  • Figure 5-1: The World Market for Prescription Generic Anesthesia Drugs Revenues 2002-2012
  • Table 5-3: The World Market for Prescription Generic Anesthesia Drugs, U.S. Revenues and Share 2002-2012
  • Figure 5-2: The World Market for Prescription Generic Anesthesia Drugs Displaying U.S. Revenues 2002-2012
  • Table 5-4: The World Market for Prescription Generic Anesthesia Drugs, Revenues and Market Share by Supplier 2007
  • Figure 5-3: The World Market for Prescription Generic Anesthesia Drugs Market Share by Leading Supplier 2007

CHAPTER SIX: ANTI-INFECTIVES

  • Table 6-1: Prescription Generic Anti-infective Drug ANDA Approvals, 2005
  • Table 6-2: The World Market for Prescription Generic Anti-Infective Drugs by Type 2002-2012
  • Figure 6-1: The World Market for Prescription Generic Anti-Infective Drugs, Revenues by Type 2002-2012
  • Table 6-3: The World Market for Prescription Generic Anti-Infective Drugs, Market Share by Type 2002-2012
  • Table 6-4: The World Market for Prescription Generic Anti-Infective Drugs U.S. Revenues and Share 2002-2012
  • Figure 6-2: The World Market for Prescription Generic Anti-Infective Drugs Displaying U.S. Revenues 2002-2012
  • Table 6-5: The World Market for Prescription Generic Anti-Infective Drugs, Revenues and Market Share by Supplier 2007
  • Figure 6-3: The World Market for Prescription Generic Anti-Infective Drugs Market Share by Leading Supplier 2007

CHAPTER SEVEN: CANCER DRUGS

  • Table 7-1: Prescription Generic Cancer Drug ANDA Approvals 2006-2007
  • Table 7-2: The World Market for Prescription Generic Cancer Drugs 2002-2012
  • Figure 7-1: The World Market for Prescription Generic Cancer Drugs Revenues 2002-2012
  • Table 7-3: The World Market for Prescription Generic Cancer Drugs, U.S. | Revenues and Share 2002-2012
  • Figure 7-2: The World Market for Prescription Generic Cancer Drugs Displaying U.S. Revenues 2002-2012
  • Table 7-4: The World Market for Prescription Generic Cancer Drugs, Revenues and Market Share by Supplier 2007
  • Figure 7-3: The World Market for Prescription Generic Cancer Drugs Market Share by Leading Supplier 2007

CHAPTER EIGHT: CARDIOVASCULAR DRUGS

  • Table 8-1: Prescription Generic Cardiovascular Drug ANDA Approvals. 2006-2007
  • Table 8-2: The World Market for Prescription Generic Cardiovascular Drugs by Type 2002-2012
  • Figure 8-1: The World Market for Prescription Generic Cardiovascular Drugs Revenues by Type 2002-2012
  • Table 8-3: The World Market for Prescription Generic Cardiovascular Drugs, Market Share by Type 2002-2012
  • Figure 8-2: The World Market for Prescription Generic Cardiovascular Drugs, Share by Type 2007 and 2012
  • Table 8-4: The World Market for Prescription Generic Cardiovascular Drugs U.S. Revenues and Share 2002-2012
  • Figure 8-3: The World Market for Prescription Generic Cardiovascular Drugs Displaying U.S. Revenues 2002-2012
  • Table 8-5: The World Market for Prescription Generic Cardiovascular Drugs, Revenues and Market Share by Supplier 2007
  • Figure 8-4: The World Market for Prescription Generic Cardiovascular Drugs, Market Share by Leading Supplier 2007

CHAPTER NINE: CENTRAL NERVOUS SYSTEM AND PSYCHOTHERAPEUTIC DRUGS

  • Table 9-1: Prescription Generic Central Nervous System/Psychotherapeutic Drug ANDA Approvals 2006-2007
  • Table 9-2: The World Market for Prescription Generic Central Nervous System Drugs by Type 2002-2012Figure 9-1: The World Market for Prescription Generic Central Nervous System Drugs Revenues by Type 2002-2012
  • Table 9-3: The World Market for Prescription Generic Central Nervous System Drugs, Market Share by Type 2002-2012
  • Table 9-4: The World Market for Prescription Generic Central Nervous System Drugs, U.S. Revenues and Share 2002-2012
  • Figure 9-2 : The World Market for Prescription Generic Central Nervous System Drugs Displaying U.S. Revenues 2002-2012
  • Table 9-5 : The World Market for Prescription Generic Central Nervous System Drugs, Revenues and Market Share by Supplier 2007
  • Figure 9-3 : The World Market for Prescription Generic Central Nervous System Drugs, Market Share by Leading Supplier 2007

CHAPTER TEN: GASTROINTESTINAL DRUGS

  • Table 10-1: Prescription Generic Gastrointestinal Drug ANDA Approvals 2006-2007
  • Table 10-2: The World Market for Prescription Generic Gastrointestinal Drugs by Type, 2002-2012
  • Figure 10-1: The World Market for Prescription Generic Gastrointestinal Drugs Revenues by Type 2002-2012
  • Table 10-3: The World Market for Prescription Generic Gastrointestinal Drugs, Market Share by Type 2002-2012
  • Figure 10-2: The World Market for Prescription Generic Gastrointestinal Drugs, Share by Type 2007 and 2012
  • Table 10-4: The World Market for Prescription Generic Gastrointestinal Drugs, U.S. Revenues and Share 2002-2012
  • Figure 10-3: The World Market for Prescription Generic Gastrointestinal Drugs, Displaying U.S. Revenues 2002-2012
  • Table 10-5: The World Market for Prescription Generic Gastrointestinal Drugs, Revenues and Market Share by Supplier 2007
  • Figure 10-4: The World Market for Prescription Generic Gastrointestinal Drugs, Market Share by Leading Supplier 2007

CHAPTER ELEVEN: HORMONAL DRUGS

  • Table 11-1: Prescription Generic Hormone Drug ANDA Approvals 2006-2007
  • Table 11-2: The World Market for Prescription Generic Hormone Drugs by Type 2002-2012
  • Figure 11-1: The World Market for Prescription Generic Hormone Drugs Revenues by Type 2002-2012
  • Table 11-3: The World Market for Prescription Generic Hormone Drugs, Market Share by Type 2002-2012
  • Figure 11-2: The World Market for Prescription Generic Hormone Drugs Share by Type 2007 and 2012
  • Table 11-4: The World Market for Prescription Generic Hormone Drugs U.S. Revenues and Share 2002-2012
  • Figure 11-3: The World Market for Prescription Generic Hormone Drugs Displaying U.S. Revenues 2002-2012
  • Table 11-5: The World Market for Prescription Generic Hormone Drugs, Revenues and Market Share by Supplier 2007
  • Figure 11-4: The World Market for Prescription Generic Hormone Drugs Market Share by Leading Supplier 2007

CHAPTER TWELVE: OPHTHALMIC DRUGS

  • Table 12-1: Prescription Generic Ophthalmic Drug ANDA Approvals 2006-2007
  • Table 12-2: The World Market for Prescription Generic Ophthalmic Drugs by Type 2002-2012
  • Figure 12-1: The World Market for Prescription Generic Ophthalmic Drugs Revenues by Type 2002-2012
  • Table 12-3: The World Market for Prescription Generic Ophthalmic Drugs, Market Share by Type 2002-2012
  • Table 12-4: The World Market for Prescription Generic Ophthalmic Drugs, U.S. Revenues and Share 2002-2012
  • Figure 12-2: The World Market for Prescription Generic Ophthalmic Drugs Displaying U.S. Revenues 2002-2012
  • Table 12-5: The World Market for Prescription Generic Ophthalmic Drugs, Revenues and Market Share by Supplier 2007
  • Figure 12-3: The World Market for Prescription Generic Ophthalmic Drugs Market Share by Leading Supplier 2007

CHAPTER THIRTEEN: WORLD MARKET SUMMARY

  • Table 13-1: The World Market for Prescription Generic Drugs Revenues by Segment 2002-2012
  • Figure 13-1: The World Market for Prescription Generic Drugs Revenues by Segment 2002-2012
  • Figure 13-2: The World Market for Generic Drugs Market Share by Type 2007 and 2012
  • Table 13-2: World Market for Prescription Generic Drugs Revenues and Segments of Participation by Leading Player 2007

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Outsourcing in Drug Discovery

    $2,062.00 – $4,152.00
  • Placeholder image

    The Market for Lead Optimization Tools and Services: Applying the New “Omics” to Enhance Drug Discovery

    $1,875.00 – $3,750.00
  • Placeholder image

    Market for Rx-to-OTC Switches, 3rd Edition, The

    $2,625.00 – $5,250.00
  • Placeholder image

    Drug Delivery Technology and Applications: A summary of Kalorama’s market research, 2001-2003

    $746.00 – $1,492.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches,...Wireless in Healthcare (Hospital, Physician Office, Pharmaceutical and other...
Scroll to top